Risk Factors for Cardiovascular Disease in Children Infected with Human Immunodeficiency Virus-1
- 31 October 2008
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 153 (4), 491-497
- https://doi.org/10.1016/j.jpeds.2008.04.016
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and WomenClinical Infectious Diseases, 2007
- Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosisAtherosclerosis, 2006
- Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in EuropeAIDS, 2004
- NATURAL HISTORY AND RISK FACTORS OF ATHEROSCLEROSIS IN CHILDREN AND YOUTH: THE PDAY STUDYPediatric Pathology & Molecular Medicine, 2002
- NATURAL HISTORY AND RISK FACTORS OF ATHEROSCLEROSIS IN CHILDREN AND YOUTH: THE PDAY STUDYPediatric Pathology & Molecular Medicine, 2002
- Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of LipodystrophyJournal of Clinical Endocrinology & Metabolism, 2001
- Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and LipodystrophyClinical Infectious Diseases, 2001
- Impact of Switching from Human Immunodeficiency Virus Type 1 Protease Inhibitors to Efavirenz in Successfully Treated Adults with LipodystrophyClinical Infectious Diseases, 2000
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998